Search
for
Sort by
Research 151–180 of 609
- Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence
- Comparative Evaluation of Biomarkers of Inflammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet
- Prescribing testosterone and DHEA: The role of androgens in women
- The metabolic syndrome- associated small G protein ARL15 plays a role in adipocyte differentiation and adiponectin secretion
- Dehydroepiandrosterone for women in the peri- or postmenopausal phase
- Hypothalamic DNA methylation in rats with dihydrotestosterone‐induced polycystic ovary syndrome: effects of low‐frequency electro‐acupuncture
- Long COVID syndrome: An unfolding enigma
- Association between Insulin Resistance and Cardiovascular Risk Factors in Polycystic Ovary Syndrome Patients
- Gynecologic and andrologic dermatology and the metabolic syndrome
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Bone Mineral Density is Unaltered in Women with Polycystic Ovary Syndrome
- Beyond Hormones: A Systematic Review of the Risk of Cardiovascular Diseases in Polycystic Ovary Syndrome
- Integrated Model of Care for Polycystic Ovary Syndrome
- Polycystic ovary syndrome: a dermatologic approach
- The role of vasoactive peptides in skin homeostasis—focus on adiponectin and the kallikrein-kinin system
- Clinical manifestations of polycystic ovary syndrome
- COVID‐19, androgens, and androgenic alopecia
- Indian Gooseberry (<i>Emblica officinalis</i>Gaertn.)
- Metformin: Old Drug, New Therapeutic Potential in the Skin? A Brief Narrative Review
- PCOS and Obesity: Contraception Challenges
- Metabolic Syndrome and Skin Disease: Potential Connection and Risk
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Debatable Topics in PCOS Patients
- Predictors of Scalp Hair Thinning in Women with Polycystic Ovary Syndrome
- Maternal androgen excess inhibits fetal cardiomyocytes proliferation through RB-mediated cell cycle arrest and induces cardiac hypertrophy in adulthood